Overview

Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate

Status:
Completed

Trial end date:
2019-04-18

Target enrollment:

Participant gender:

Summary

The purpose of the AR19.004 study is to assess the efficacy of AR19 compared to placebo using the Adult ADHD Investigator Symptom Rating Scale (AISRS)

Phase:

Phase 3

Details

Lead Sponsor:

Arbor Pharmaceuticals, Inc.

Treatments:

Amphetamine